ProteInProgress: a cellular assembly line for protein manufacturing

Implementation and Results

Self-inducible promoters

Regulation of signal protein productuion

Experimental implementation: <partinfo>BBa_K300009</partinfo> part was assembled downstream of different constitutive promoters, thus obtaining a signal molecule generator. The choice of constitutive promoters was performed between the ones belonging to the [http://partsregistry.org/Part:BBa_J23101 Anderson’s promoters collection] ; we chose promoters according to their activities reported in the Registry of Standard Biological Parts, in order to have a thick mesh:

Before constructing the signal generators, <partinfo>BBa_K300009</partinfo> under the regulation of one of these constitutive promoters, we evaluated their activities in Relative Promoter Units (R.P.U.) according to Data analysis for RPU evaluation, using the reporter protein R.F.P. in different experimental conditions (plasmids’ copy number and growth medium) :

• high copy number plasmids and LB;
• high copy number plasmids and M9;
• low copy number plasmids and M9.

It was not possible to evaluate promoters activities in low copy number plasmids and LB because the RFP activity was too weak and not detectable and discernible from the background. Red Fluorescent Protein (RFP) fluorescence and Optical Density at 600nm (O.D.600) were measured by Tecan Infinite F200 as reported in Microplate reader experiments for constitutive promoters (R.P.U. evaluation) - Protocol #2 and data were analyzed as reported in DATA Analysis RPU;

Results: results are shown here.

Figure 5 - R.P.U. of some promoters from Anderson promoters' collection, LB medium and high copy plasmid (<partinfo>BBa_J61002</partinfo>)

Figure 6 - R.P.U. of some promoters from Anderson promoters' collection, M9 medium and high copy plasmid (<partinfo>BBa_J61002</partinfo>)

Figure 7 - R.P.U. of some promoters from Anderson promoters' collection, M9 medium and low copy plasmid (<partinfo>pSB4C5</partinfo>)

Discussion: we observed that the Registry ranking is not always respected. As an example, <partinfo>BBa_J23110</partinfo> in high copy plasmid is stronger than <partinfo>BBa_J23118</partinfo>, in contrast with the ranking of the Registry.

After the evaluation of promoters’ activity, signal generators were constructed in high copy and low copy plasmids: <partinfo>BBa_K300009</partinfo> and <partinfo>BBa_K300010</partinfo> were assembled downstream the above mentioned promoters, thus obtaining the following parts:

BioBrick	Description
<partinfo>BBa_K300030</partinfo>	J23118
<partinfo>BBa_K300028</partinfo>	J23110
<partinfo>BBa_K300029</partinfo>	J23116
<partinfo>BBa_K300025</partinfo>	J23101
<partinfo>BBa_K300026</partinfo>	J23105
<partinfo>BBa_K300027</partinfo>	J23106
<partinfo>BBa_K300017</partinfo>	J23118
<partinfo>BBa_K300014</partinfo>	J23110
<partinfo>BBa_K300015</partinfo>	J23114
<partinfo>BBa_K300016</partinfo>	J23116
<partinfo>BBa_K300012</partinfo>	J23105

Some of the promoters probably induce a production of LuxI that is injurious for E. coli, so it wasn’t possible to exploit all the combinations. For every part, a measurement system was built, exploiting the production of the reporter gene GFP to evaluate the trascription initiation point for every promoter. Many different combination were explored, in order to provide a library of promoters capable of initiate transcription at the desired culture density.

Quantification of the HSL produced

Experimental implementation The new parts were, thus, characterized, measuring the HSL concentration released in the medium after a 6 hour growth of the cultures. All the details are available in this section.

<partinfo>BBa_T9002</partinfo> sensor was contained in <partinfo>pSB1A3</partinfo> in E. coli TOP10.

Results The amount of 3OC6-HSL produced after 6 hours growth by E. coli DH5alpha bearing the parts contained in high copy plasmid <partinfo>pSB1A2</partinfo> is reported in Figure 8 and in the table:

Figure 8 - <partinfo>BBa_T9002</partinfo> calibration curve for detection of [HSL] produced in high copy plasmid

The amount of 3OC6-HSL produced after 6 hours growth by the parts contained in low copy plasmid <partinfo>pSB4C5</partinfo> is reported in Figure 9 and in the table:

Figure 9 - <partinfo>BBa_T9002</partinfo> calibration curve for detection of [HSL] produced in low copy plasmid

Discussion These experiments provided extremely useful informations about the capability of the signal generator to produce 3OC6-HSL signal molecule. Data are partially uncompleted because for weak promoters ore medium-strength promoters contained in low copy number plasmid the amount of 3OC6-HSL was not detectable using this system. This simple experiment shows that there's a strong correlation between the strength of promoter and the amount of signal molecule produced, even if the correspondence is not exact, probably due to the fact that very strong promoters (such as <partinfo>BBa_J23101</partinfo>) give to the cells a high metabolic burden, thus resulting in lower production yields.

Modulation of plasmid copy number

Signal generator and sensor device were assembled in an unique part (such as <partinfo>BBa_K300017</partinfo>, <partinfo>BBa_K300014</partinfo>, <partinfo>BBa_K300015</partinfo>, <partinfo>BBa_K300016</partinfo> and <partinfo>BBa_K300012</partinfo>) beared on high copy number plasmid <partinfo>pSB1A2</partinfo> or low copy number plasmid <partinfo>pSb4C5</partinfo>. A third alternative was the assembly of signal generator on a low copy number plasmid (<partinfo>pSB4C5</partinfo>) and the receiver device on high number plasmid (<partinfo>pSB1A2</partinfo>). The circuits we obtained and tested are summarized here:

BioBrick Sender	Description	Sender Vector	<partinfo>BBa_F2620</partinfo> Receiver vector	BioBrick composite part
<partinfo>BBa_K300030</partinfo>	J23118	<partinfo>pSB1A2</partinfo> HC		<partinfo>BBa_K300017</partinfo>
<partinfo>BBa_K300028</partinfo>	J23110	<partinfo>pSB1A2</partinfo> HC		<partinfo>BBa_K300014</partinfo>
<partinfo>BBa_K300029</partinfo>	J23116	<partinfo>pSB1A2</partinfo> HC		<partinfo>BBa_K300016</partinfo>
<partinfo>BBa_K300026</partinfo>	J23105	<partinfo>pSB1A2</partinfo> HC		<partinfo>BBa_K300012</partinfo>
xxx	J23114	<partinfo>pSB1A2</partinfo> HC		<partinfo>BBa_K300015</partinfo>
<partinfo>BBa_K300030</partinfo>	J23118	<partinfo>pSB4C5</partinfo> LC		<partinfo>BBa_K300017</partinfo>
<partinfo>BBa_K300028</partinfo>	J23110	<partinfo>pSB4C5</partinfo> LC		<partinfo>BBa_K300014</partinfo>
<partinfo>BBa_K300029</partinfo>	J23116	<partinfo>pSB4C5</partinfo> LC		<partinfo>BBa_K300016</partinfo>
<partinfo>BBa_K300026</partinfo>	J23105	<partinfo>pSB4C5</partinfo> LC		<partinfo>BBa_K300012</partinfo>
<partinfo>BBa_K300030</partinfo>	J23118	<partinfo>pSB4C5</partinfo> LC	<partinfo>pSB1A2</partinfo> HC	Parts are contained in two different vectors
<partinfo>BBa_K300028</partinfo>	J23110	<partinfo>pSB4C5</partinfo> LC	<partinfo>pSB1A2</partinfo> HC	Parts are contained in two different vectors
<partinfo>BBa_K300029</partinfo>	J23116	<partinfo>pSB4C5</partinfo> LC	<partinfo>pSB1A2</partinfo> HC	Parts are contained in two different vectors
<partinfo>BBa_K300025</partinfo>	J23101	<partinfo>pSB4C5</partinfo> LC	<partinfo>pSB1A2</partinfo> HC	Parts are contained in two different vectors
<partinfo>BBa_K300026</partinfo>	J23105	<partinfo>pSB4C5</partinfo> LC	<partinfo>pSB1A2</partinfo> HC	Parts are contained in two different vectors
<partinfo>BBa_K300027</partinfo>	J23106	<partinfo>pSB4C5</partinfo> LC	<partinfo>pSB1A2</partinfo> HC	Parts are contained in two different vectors

Results

The following measurement systems were realized assembling GFP downstream of each self-inducible device. The parts characterized are reported in this table:

Sender device	Sensor systems with GFP	Measurement Device
<partinfo>BBa_K300030</partinfo> in <partinfo>pSB1A2</partinfo> J23118	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A2</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300024</partinfo> in <partinfo>pSB1A2</partinfo>
<partinfo>BBa_K300028</partinfo> in <partinfo>pSB1A2</partinfo> J23110	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A2</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300021</partinfo> in <partinfo>pSB1A2</partinfo>
<partinfo>BBa_K300029</partinfo> in <partinfo>pSB1A2</partinfo> J23116	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A2</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300022</partinfo> in <partinfo>pSB1A2</partinfo>
<partinfo>BBa_K300026</partinfo> in <partinfo>pSB1A2</partinfo> J23105	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A2</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300019</partinfo> in <partinfo>pSB1A2</partinfo>
xxx J23114	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A2</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300023</partinfo> in <partinfo>pSB1A2</partinfo>
<partinfo>BBa_K300030</partinfo> in <partinfo>pSB4C5</partinfo> J23118	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB4C5</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300024</partinfo> in <partinfo>pSB4C5</partinfo>
<partinfo>BBa_K300028</partinfo> in <partinfo>pSB4C5</partinfo> J23110	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB4C5</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300021</partinfo> in <partinfo>pSB4C5</partinfo>
<partinfo>BBa_K300029</partinfo> in <partinfo>pSB4C5</partinfo> J23116	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB4C5</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300022</partinfo> in <partinfo>pSB4C5</partinfo>
<partinfo>BBa_K300026</partinfo> in <partinfo>pSB4C5</partinfo> J23105	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB4C5</partinfo> in <partinfo>pSB1A2</partinfo>	<partinfo>BBa_K300019</partinfo> in <partinfo>pSB4C5</partinfo>
<partinfo>BBa_K300030</partinfo> in <partinfo>pSB4C5</partinfo> J23118	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A3</partinfo> in <partinfo>pSB1A2</partinfo>	Sender and Receiver are contained in two different plasmids, cotransformed in the same cell
<partinfo>BBa_K300028</partinfo> in <partinfo>pSB4C5</partinfo> J23110	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A3</partinfo> in <partinfo>pSB1A2</partinfo>	Sender and Receiver are contained in two different plasmids, cotransformed in the same cell
<partinfo>BBa_K300029</partinfo> in <partinfo>pSB4C5</partinfo> J23116	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A3</partinfo> in <partinfo>pSB1A2</partinfo>	Sender and Receiver are contained in two different plasmids, cotransformed in the same cell
<partinfo>BBa_K300026</partinfo> in <partinfo>pSB4C5</partinfo> J23105	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A3</partinfo> in <partinfo>pSB1A2</partinfo>	Sender and Receiver are contained in two different plasmids, cotransformed in the same cell
<partinfo>BBa_K300025</partinfo> in <partinfo>pSB4C5</partinfo> J23101	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A3</partinfo> in <partinfo>pSB1A2</partinfo>	Sender and Receiver are contained in two different plasmids, cotransformed in the same cell
<partinfo>BBa_K300027</partinfo> in <partinfo>pSB4C5</partinfo> J23106	<partinfo>BBa_T9002</partinfo> in <partinfo>pSB1A3</partinfo> in <partinfo>pSB1A2</partinfo>	Sender and Receiver are contained in two different plasmids, cotransformed in the same cell

Cultures of E. coli TOP10 bearing the plasmids containing the self-inducible devices expressing G.F.P. were grown according to this protocol and all data collected were analyzed as explained in this section

Growth curve of <partinfo>BBa_K300019</partinfo> (O.D.600)	Fluorescence curve of <partinfo>BBa_K300019</partinfo> (G.F.P.)
Fluorescence VS Optical density curve of <partinfo>BBa_K300019</partinfo>	Scell=(dGFP/dt)/O.D.600 and threshold

Doubling times were estimated as explained here Thus, these BioBrick parts can be used to express recombinant proteins without adding an inducer to trigger the transcription of their genes; in large-scale production of such proteins this strategy could be also cost saving.

For every self-inducible device, several parameters were evaluated, as reported in this section. Results are summarized in the following tables:

TOGLIMI

Tab. 1 - Sender and Receiver on high copy plasmid <partinfo>pSB1A2</partinfo>

Self-inducible device	Description	O.D.start LB	K_HSL LB	Doubling time LB	O.D.start M9	K_HSL M9	Doubling time M9
<partinfo>BBa_K300017</partinfo> (wiki name: I7) in <partinfo>pSB1A2</partinfo> plasmid
<partinfo>BBa_K300014</partinfo> (wiki name: I8) in <partinfo>pSB1A2</partinfo> plasmid
<partinfo>BBa_K300015</partinfo> (wiki name: I9) in <partinfo>pSB1A2</partinfo> plasmid
<partinfo>BBa_K300016</partinfo> (wiki name: I10) in <partinfo>pSB1A2</partinfo> plasmid
<partinfo>BBa_K300012</partinfo> (wiki name: I12) in <partinfo>pSB1A2</partinfo> plasmid

Tab. 2 - Sender and Receiver on low copy plasmid <partinfo>pSB4C5</partinfo>

Self-inducible device	Description	O.D.start LB	K_HSL LB	Doubling time LB	O.D.start M9	K_HSL M9	Doubling time M9
<partinfo>BBa_K300017</partinfo> (wiki name: I7) in <partinfo>pSB1A2</partinfo> plasmid		Not detectable	Not detectable	Not detectable
<partinfo>BBa_K300014</partinfo> (wiki name: I8) in <partinfo>pSB1A2</partinfo> plasmid		Not detectable	Not detectable	Not detectable	Not detectable	Not detectable	Not detectable
<partinfo>BBa_K300015</partinfo> (wiki name: I9) in <partinfo>pSB1A2</partinfo> plasmid		Not detectable	Not detectable	Not detectable	Not detectable	Not detectable	Not detectable
<partinfo>BBa_K300016</partinfo> (wiki name: I10) in <partinfo>pSB1A2</partinfo> plasmid		Not detectable	Not detectable	Not detectable	Not detectable	Not detectable	Not detectable
<partinfo>BBa_K300012</partinfo> (wiki name: I12) in <partinfo>pSB1A2</partinfo> plasmid		Not detectable	Not detectable	Not detectable	Not detectable	Not detectable	Not detectable

Tab. 3 - Sender on low copy plasmid <partinfo>pSB4C5</partinfo> and Receiver on high copy plasmid <partinfo>pSB1A3</partinfo>

Self-inducible device	Description	O.D.start LB	K_HSL LB	Doubling time LB	O.D.start M9	K_HSL M9	Doubling time M9
<partinfo>BBa_K300030</partinfo> (wiki name: I14) in <partinfo>pSB4C5</partinfo> plasmid	+ LC &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp HC
<partinfo>BBa_K300028</partinfo> (wiki name: I15) in <partinfo>pSB4C5</partinfo> plasmid	+ LC HC
<partinfo>BBa_K300029</partinfo> (wiki name: I16) in <partinfo>pSB4C5</partinfo> plasmid	+ LC HC
<partinfo>BBa_K300025</partinfo> (wiki name: I17) in <partinfo>pSB4C5</partinfo> plasmid	+ LC HC
<partinfo>BBa_K300026</partinfo> (wiki name: I18) in <partinfo>pSB4C5</partinfo> plasmid	+ LC HC
<partinfo>BBa_K300027</partinfo> (wiki name: I19) in <partinfo>pSB4C5</partinfo> plasmid	+ LC HC

Average growth curve with ODstart evaluated by Threshold algorithm in LB

Average growth curve with ODstart evaluated by Threshold algorithm in M9

Integrative standard vector for E. coli

Materials and Methods

Plasmids and strains: the <partinfo>BBa_J72008</partinfo> helper plasmid was kindly given by Prof. JC Anderson (UC Berkeley). MC1061 (<partinfo>BBa_K300078</partinfo>) and MG1655 (<partinfo>BBa_V1000</partinfo>) E. coli strains and the pCP20 helper plasmid were purchased from the Coli Genetic Stock Center (Yale University). DH5alpha (<partinfo>BBa_V1001</partinfo>) strain was purchased from Invitrogen.

Verification primers: all the oligonucleotides were purchased from Primm (San Raffaele Biomedical Science Park, Milan, Italy). The P1 (<partinfo>BBa_K300975</partinfo>) and P4 (<partinfo>BBa_K300978</partinfo>) primers had already been used in [Anderson JC et al., 2010]. The P2 (<partinfo>BBa_K300976</partinfo>) and P3 (<partinfo>BBa_K300977</partinfo>) primers have been newly designed using ApE and amplifiX. P2 and P3 have been designed also considering the previously used verification primers P2 and P3 in the pG80ko integrative plasmid, described in [DeLoache W, 2009].

The relative position of the P1, P2, P3 and P4 primers is shown in the figure below:

Relative position of the verification primers. a) no integrants; b) single integrant and c) integrant with multiple tandem copies. P1/P2 and P3/P4 pairs give an amplicon when at least one copy of the vector is integrated in the Phi80 locus. P2/P3 pair show an amplicon only when multiple tandem copies occur.

Competent cells preparation: all the E. coli strains were made competent following a slightly modified version of the protocol described in [Sambrook J et al., 1989]. Briefly, cells were grown to and OD600 of ~0.4-0.6, harvested (4000 rpm, 10 min, 4°C) and the supernatant discarded. Cells were resuspended in (30 ml for each 50 ml of initial culture) pre-chilled Mg-Ca buffer (80 mM MgCl2, 20 mM CaCl2), centrifuged as before and the supernatant discarded. Cells were resuspended in (2 ml for each 50 ml of initial culture) pre-chilled Ca buffer (100 mM CaCl2, 15% glycerol), aliquoted in 0.5 ml tubes and freezed immediately at -80°C. Test the transformation efficiency as:

Pir strains validation: in order to test the capability of BW25141 (pir+) and BW23474 (pir-116) to propagate this conditional replication origin, they were made competent, as well as three control strains: MC1061, MG1655 and DH5alpha. Then, a vial of 100 ul of competent cells was transformed with 2-4 ng of:

• no DNA (negative control);
• a pSB*** series vector (positive control);
• self-ligated <partinfo>BBa_K300008</partinfo> (a R6K plasmid with Cm resistance).

Self-ligated <partinfo>BBa_K300008</partinfo> was prepared by digesting <partinfo>pSB1A2</partinfo>-<partinfo>BBa_K300008</partinfo> (yielded by BioBrick Standard Assembly) with XbaI-SpeI. The insert was isolated and purified from a 1% agarose gel. Then, it was self-ligated to generate a Cm-resistant R6K plasmid. The colonies were counted in each plate and the transformation efficiency was estimated as described before.

The Chloramphenicol concentration in plates was 34 ug/ml for the high copy plasmids, 12.5 ug/ml for the medium/low copy plasmids and 12.5 for the three control strains transformed with the R6K plasmid.

BBa_K300000 construction: This section describes how this vector backbone was assembled using BioBrick parts.

1. First step - <partinfo>BBa_K300982</partinfo> intermediate part construction:
   1. <partinfo>BBa_K300983</partinfo>, provided by Mr Gene DNA synthesis service (www.mrgene.com), was excised from its original shipping vector (pMK-RQ) through digestion with AvrII restriction enzyme (Roche). It was then isolated through a 1% agarose gel electrophoresis and gel-extracted (Macherey-Nagel NucleoSpin Extract II).
   2. <partinfo>BBa_K300008</partinfo> was assembled via BioBrick Standard Assembly from available parts and was excised from its vector (<partinfo>pSB1A2</partinfo>) through digestion with XbaI-SpeI (Roche). It was then isolated using the same procedure described above and it was dephosphorylated by using Antarctic Phosphatase (NEB).
   3. Digested <partinfo>BBa_K300983</partinfo> and <partinfo>BBa_K300008</partinfo>, all having compatible sticky ends, were ligated with T4 Ligase (Roche) and transformed into competent BW23474 E. coli strain (<partinfo>BBa_K300985</partinfo>) in order to allow the ligated plasmid propagation at high copy number. This strain was necessary because the replication origin of the resulting plasmid was the conditional R6K origin (<partinfo>BBa_J61001</partinfo>).
   4. Positive transformants, grown on Chloramphenicol (34 ug/ml) plates, were identified by restriction mapping with EcoRI-HindIII (Roche). The yielded plasmid was <partinfo>BBa_K300982</partinfo>.
2. Second step - <partinfo>BBa_K300000</partinfo> final vector construction:
   1. <partinfo>BBa_K300982</partinfo> DNA was miniprepped, digested with EcoRI-PstI (Roche), run on agarose gel and gel-extracted as described above, in order to cut out and eliminate the RBS (<partinfo>BBa_B0033</partinfo>) between EcoRI and PstI.
   2. <partinfo>BBa_I52002</partinfo> DNA was excised from <partinfo>pSB4C5</partinfo> by EcoRI-PstI (Roche) digestion and isolated by gel run and gel extraction as described above.
   3. Digested <partinfo>BBa_K300982</partinfo> and <partinfo>BBa_I52002</partinfo> were ligated and transformed into competent DB3.1 E. coli strain (<partinfo>BBa_V1005</partinfo>), selected with Chloramphenicol at 34 ug/ml.
   4. Positive transformants were screened by restriction mapping with EcoRI-HindIII (Roche) and sequencing with VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00101</partinfo>) standard primers. The yielded plasmid was <partinfo>BBa_K300000</partinfo>.

All the DNA manipulations were performed according to manufacturer's protocols.

Integration protocol:

1. Transform the <partinfo>BBa_J72008</partinfo> helper plasmid in the host strain (MC1061 or MG1655) and select transformants on Amp (50 ug/ml) plates under permissive conditions (30°C) overnight.
2. Inoculate a single colony in selective LB and let the culture grow at 30°C, 220 rpm. When the culture reaches the OD600 of 0.4-0.6 prepare chemically competent cells.
3. Transform the integrative vector with the desired insert in the BBa_J72008-containing strain and select co-transformants on Cm (34 ug/ml) plates under permissive conditions (30°C) overnight. At this temperature <partinfo>BBa_J72008</partinfo> can be replicated and so the pir protein product can be expressed in the cells. The pir product enables the propagation of the integrative vector by replicating the R6K origin.
4. Inoculate a single colony in 5 ml of LB + Cm at 12.5 ug/ml and incubate the culture at 37°C, 220 rpm overnight. At this temperature the <partinfo>BBa_J72008</partinfo> helper cannot be replicated and the Phi80 integrase is expressed by the remaining copies of the helper. The bacteria that are able to grow in this selective medium should be correct integrants because the integrative vector cannot be replicated by the pir product anymore.
5. Streak the culture on a Cm plate (at 12.5 ug/ml) and incubate it at 43°C overnight to ensure the loss of the helper plasmid. The bacteria that form colonies should be correct integrants without the <partinfo>BBa_J72008</partinfo> helper plasmid.

Validate the loss of the helper plasmid by inoculating colonies in Cm (at 12.5 ug/ml) media and counterselecting them in Amp (at 50 ug/ml) media. Validate the correct integration position by performing colony PCR with primers P1/P2, P3/P4, P1/P4, P2,P3 and VF2/VR. Validate the phenotype (when possible).

Expected amplicon length [bp] when the vector is integrated into the Phi80 locus:

Marker excision protocol:

1. Inoculate an integrant in selective LB medium and let it grow to OD600=0.4-0.6. Prepare chemically competent cells.
2. Transform the pCP20 helper plasmid in the competent strain and select transformants on Amp (100 ug/ml) plates under permissive conditions (30°C) overnight. At this temperature the pCP20 can be replicated. The pCP20 plasmid contains Amp and Cm resistance markers, a thermoinducible Flp recombinase expression system and a heat-sensitive replication origin. The permissive temperatures for the pCP20 propagation are the same as <partinfo>BBa_J72008</partinfo>.
3. Inoculate a single colony in 5 ml of LB without antibiotic and incubate the culture at 37°C, 220 rpm overnight. At this temperature the pCP20 helper cannot be replicated and the Flp recombinase is expressed by the remaining copies of the helper. The bacteria should loose the R6K origin and the Cm resistance upon FRT sites recombination, mediated by Flp.
4. Streak the culture on a LB plate and incubate it at 43°C overnight to ensure the loss of the helper plasmid. The bacteria that form colonies should be without the pCP20 helper plasmid.

Validate the loss of the helper plasmid by inoculating colonies in Amp (at 100 ug/ml) media and validate the loss of the Cm resistance from the genome by inoculating colonies in Cm (at 12.5 ug/ml) media. Validate the correct length of the integrated part without Cm resistance and R6K origin by performing colony PCR with primers P1/P4 (which amplify the entire Phi80 locus) and VF2/VR (which amplify the integrated part). Validate the phenotype (when possible).

Colony PCR: a single colony or 1 ul of culture was added to the Invitrogen Platinum Taq reaction mix and was heated at 94°C for 10 min. Then it was assayed with this cycle (X 35): 94°C 30 sec, 60°C (for VF2/VR) or 63°C (for the other primers) 30 sec, 72°C according to the amplicon expected length (1Kb/min). Then the reaction was kept at 72°C for 10 min and it was run on a 1% agarose gel with the GeneRuler 1Kb Plus DNA ladder (Fermentas).

Fluorescence assays: integrants were inoculated in 1 ml of M9 + Cm (12.5 ug/ml) and grown at 37°C, 220 rpm overnight. The cultures were diluted 1:100 in 2 ml of selective M9 and let grow for about 4-6 hours under the same conditions as before. Three 200 ul aliquots for each culture were transferred to a 96-well microplate and assayed in the Infinite F200 microplate reader (Tecan) for about 20 hours with the following kinetic cycle: 37°C, 5 min sampling time, linear shaking 15 sec (amplitude=3), wait 5 sec, measure OD600, measure fluorescence with the proper filter (EX:nm/EM:540nm for GFP or EX:535nm/EM:620nm for RFP) with gain=50 or 70. The same protocol was followed for the MC1061 and the MG1655 non-integrant strains, which were grown in M9 without antibiotic.

Results

Validation of pir strains to propagate the R6K replication origin

The BW25141 (pir+) and BW23474 (pir-116) E. coli strains were chosen to propagate the vectors with the R6K replication origin at medium copy (~15 molecules per cell) and high copy (~250) respectively. The results about their capability to propagate R6K plasmids are shown here:

These results show that the R6K conditional replication origin can be only propagated in pir+ and pir-116 strains (<partinfo>BBa_K300084</partinfo> and <partinfo>BBa_K300085</partinfo>), while the transformation of other strains with the R6K plasmid yielded no colonies after transformation. The exception was MG1655, for which six small unwanted colonies appeared on the selective plate. Plasmid DNA was purified/HindIII-digested/gel-run for at least one colony for BW25141-<partinfo>BBa_K300008</partinfo> and BW23474-<partinfo>BBa_K300008</partinfo>, while all the six colonies were analyzed for MG1655-<partinfo>BBa_K300008</partinfo> plate. The electrophoresis showed the expected length of the transformed DNA for all the clones except for the MG1655 six colonies, for which a smear was present in the lane (data not shown). Probably, Cm-resistant contaminants were present in the MG1655 culture during the preparation of competent cells.

For this reason, competent cells were prepared again for MG1655 and the transformation procedure was repeated for this strain, yielding no colonies in the <partinfo>BBa_K300008</partinfo> plate as expected.

Miniprep of the BW25141 and BW23474 strains transformed with <partinfo>BBa_K300008</partinfo> yielded a DNA concentration of ~20 ng/ul (qualitatively comparable with medium copy number plasmids) and ~90-100 ng/ul (qualitatively comparable with high copy number plasmids). The results shown in the table above also show that the R6K plasmid in pir+ and pir-116 strains was transformed with the same efficiency as the pSB*** positive control plasmid, demonstrating that the R6K origin doesn't give any handicap in plasmid transformation. So, the BW25141 and BW23474 strains can be successfully used to propagate the integrative vector after the excision of the pUC19-derived high copy replication origin, present in the default insert <partinfo>BBa_I52002</partinfo>.

Integration of the desired BioBrick part into the Phi80 genome locus

MC1061 and MG1655 were chosen as host strains for integration. <partinfo>BBa_K173001</partinfo> (constitutive strong promoter with GFPmut3) and the EcoRI-PstI fragment of <partinfo>BBa_J61002</partinfo>-<partinfo>BBa_J23101</partinfo> (here called PconRFP - constitutive strong promoter with RFP) were chosen as two proof of concept BioBrick parts to test the integration capability of the <partinfo>BBa_K300000</partinfo> vector in the Phi80 genome locus of these strains. For this reason, <partinfo>BBa_K173001</partinfo> and PconRFP were ligated in <partinfo>BBa_K300000</partinfo> (digested with EcoRI-PstI) and propagated using BW23474. The integration protocol was performed as described in the Materials and Methods section for 4 different combination:

Three colonies grown after the overnight incubation at 43°C (step 5 of integration protocol) were analyzed for each plate. These 12 clones were called: MC-GFP-A,B,C , MC-RFP-A,B,C , MG-GFP-A,B,C and MG-RFP-A,B,C.

Validation of the loss of BBa_J72008: all the picked colonies did not grow in Amp (50 ug/ml) media, thus validating that <partinfo>BBa_J72008</partinfo> Amp-resistant helper had been actually cured from the cells. However, one of these 12 clones (MG-GFP-A) also failed to grow in Cm (12.5 ug/ml) liquid media, probably because of a mistake in its inoculation. We decided not to consider this clone and to continue with 11 clones.

Validation of the actual integration site

Validation of the integrants phenotype

Chloramphenicol resistance marker excision

Although MC-RFP and MG-RFP were actually multiple integrants, they were chosen as engineered strains for marker excision validation.

The marker excision protocol was performed as described in the Materials and Methods section for both strains, here named:

Three colonies grown after the overnight incubation at 43°C (step 4 of marker excision protocol) were analyzed for each plate. These 6 clones were called MC-RFPflip-A,B,C and MG-FRPflip-A,B,C.

Validation of the loss of pCP20 and the resistance marker: all the 6 picked colonies failed to grow on both Amp (100 ug/ml) media and Cm (12.5 ug/ml) media. They could only grow in LB without antibiotics, thus validating that the pCP20 helper had been actually cured and the R6K-CmR DNA containing the Chloramphenicol selection marker had been actually eliminated.

Validation of the length of the integrated part:

Validation of the marker-less phenotype:

Discussion

A novel integrative vector for E. coli has been successfully designed, constructed and used to integrate two proof of concept protein expression systems in two commonly used E. coli strains.

The results showed that the vector is fully functional and can integrate into the correct targeted locus of the host chromosome through the Phi80 site-specific recombination system by using <partinfo>BBa_J72008</partinfo>, an existing BioBrick helper plasmid from the Registry. In most cases, the integration occurs in tandem copies, probably because of the too high Chloramphenicol concentration used during the selection of integrants, which forces multiple integration of Cm-resistant constructs. This concentration was the same used during the pSC101 low copy plasmid (~5 copies per cell) selection. In some cases, it is desirable to have a single copy of the desired BioBrick in the genome, for example when the gene dosage is important. In [Haldimann A and Wanner BL, 2001] the usage of Chloramphenicol at 6 ug/ml yielded a very high percentage of single integrants. However, when tested in our lab, the MG1655 strain could survive on LB plates with Cm at 6 ug/ml and also at 8 ug/ml. For this reason a higher concentration of Cm was chosen for selection. Further studies should investigate the optimal antibiotic concentration to yield the highest single integrants percentage as possible.

The Flp/FRT mediated excision of the R6K and, most importantly, of the Cm resistance marker also worked by using the pCP20 helper plasmid. The estimated efficiency of this process was 100%. In addition, multiple tandem integrants became single integrants after the marker excision. This is because the Flp recombinase mediated the recombination of all the FRT sites of the multiple integrants until only a single FRT site was present in the Phi80 locus. The marker excision is a powerful tool to engineer microbial strains for industrial protein manufacturing because the engineered organism should not carry unsafe antibiotic resistances that may be diffused in the environment.

The fluorescence phenotype confirmed the correct integration into the E. coli chromosome. As expected, in general multiple integrants showed a higher fluorescence than the single integrants.

The BioBrick compatibility and the vector modularity give the possibility to the scientific community to stably engineer novel biological functions in E. coli with a very easy and user friendly methodology. A user’s handbook about the vector usage is shared in the Registry, as well as the users experiences and the compatibility information.

Integrative standard vector for yeast

Materials and Methods

Strain: the S. cerevisiae S288C strain (<partinfo>BBa_K300979</partinfo>, genotype: MATα ρ° trp1-0) was purchased from Open Biosystems.

Construction of BBa_K300001:

1. <partinfo>BBa_K300980</partinfo>, provided by Mr Gene DNA synthesis service (www.mrgene.com), was excised from its original shipping vector (pMA) through digestion with MfeI (Fermentas) and NsiI (Fermentas) restriction enzymes. It was then isolated through a 1% agarose gel electrophoresis and gel-extracted (Macherey-Nagel NucleoSpin Extract II).
2. <partinfo>BBa_I763007</partinfo>, available in the Registry, was digested with EcoRI-PstI (Roche), ran on agarose gel and its <partinfo>pSB1A2</partinfo> vector was gel-extracted as described above.
3. Digested <partinfo>BBa_K300980</partinfo> and <partinfo>pSB1A2</partinfo> have compatible ends (EcoRI-MfeI and PstI-NsiI). They were ligated with T4 Ligase (Roche) and transformed into competent TOP10 E. coli strain (<partinfo>BBa_V1009</partinfo>) which were then plated on Ampicillin (100 ug/ml) plates.
4. Positive transformants were identified by colony PCR with VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00101</partinfo>) standard primers and by restriction mapping with EcoRI (Roche) or NsiI (Fermentas). The yielded plasmid had <partinfo>BBa_B0033</partinfo> flanked by EcoRI and SpeI.
5. The yielded plasmid was then digested with EcoRI-SpeI (Roche) and <partinfo>BBa_K300007</partinfo> (digested with EcoRI-SpeI as well) was assembled in the vector, thus yielding <partinfo>BBa_K300001</partinfo>-<partinfo>BBa_K300007</partinfo> (i.e. there is the <partinfo>BBa_K300007</partinfo> part in the cloning site).

Yeast transformation:

1. S288C strain was inoculated in 5 ml of YPD from a long term 15% glycerol stock and grown for 24h (30°C, 200rpm).
2. The culture was diluted 1:10 in 50 ml of pre-warmed YPD in a 250 ml flask and was grown for additional 4 hours under the same conditions as before.
3. Cells were pelleted (4000 rpm, 5 min) and resuspended in 25 ml of deionized water.
4. Cells were pelleted (4000 rpm, 5 min), the supernatant was discarded and the pellet was resuspended in 1 ml of deionized water and transferred into a 1.5 ml tube.
5. Cells were pelleted (4000 rpm, 30 sec), the supernatant was discarded and the pellet was resuspended in deionized water to a final volume of 1 ml (vortex mix vigorously).
6. Three 100 ul aliquots were transferred into 1.5 ml tubes, while the remaining 600 ul of cells were not used in this protocol.
7. The three tubes were centrifuged (4000 rpm, 30 sec) and the supernatant discarded.
8. Each of the three pellets were resuspended (vortex mix vigorously) in 360 ul of transformation mix (240 ul of PEG 3350 50% w/v, 36 ul of LiAc 1.0 M, boiled salmon sperm DNA, 34 ul of linearized plasmid DNA plus water). The salmon sperm DNA was boiled for 5 min and pre-chilled before adding it in the transformation mix. The plasmid DNA was previously digested with SbfI (Fermentas), purified with the NucleoSpin Extract II kit (MN) and quantified with the NanoDrop in order to add 0.5-1 ug of DNA to the transformation mix.
9. The tubes were heated at 42°C for 40 min.
10. Cells were pelleted (4000 rpm, 30 sec), the supernatant was removed by pipetting and the pellet was gently resuspended in 1 ml of deionized water.
11. Cells were pelleted (4000 rpm, 30 sec), the supernatant was discarded, the pellet was resuspended in 1 ml of YPD and incubated at 30°C, 200 rpm for 3 hours.
12. Cells were pelleted (4000 rpm, 30 sec), resuspended in 200 ul of YPD and plated on a YPD agar plate with G418 antibiotic at 200 ug/ml.
13. The plates were incubated at 30°C for about 3 days until colonies appeared.

The integration efficiency was estimated as the colony forming units (CFUs) yielded for each ug of DNA.

Protocol references:

[1] http://openwetware.org/wiki/High_Efficiency_Transformation

[2] Guldener U, Heck S, Fiedler T, Beinhauer J, Hegemann JH (1996), A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Research, Vol. 24, No. 13 2519–2524.

Results

The transformed inserts and their integration efficiency in S288C are listed here:

The colony count was quite difficult (see pictures), but it is useful to have an estimation of the integration efficiency.

S288C transformed with no DNA (negative control).

S288C transformed with linearized <partinfo>BBa_K300001</partinfo>-<partinfo>BBa_K300006</partinfo>.

S288C transformed with linearized <partinfo>BBa_K300001</partinfo>-<partinfo>BBa_K300007</partinfo>.

Discussion

The obtained results suggest that the integrative vector actually works and that the selection marker is highly specific (no colonies appeared on the "no DNA" plate).

Although this integrative vector has already given promising integration results, a lot of work still remains to do:

• the correct phenotype of the S288C bearing these parts has to be validated (by mOrange fluorescence measurement for the <partinfo>BBa_K300007</partinfo> part);
• the actual integration position has to be confirmed by PCR with ad hoc-designed primers;
• the KanMX selection marker excision has to be validated.

The compatibility with the BioBrick standard (RFC10, RFC12 and RFC23) enables the engineering the chromosomes of S. cerevisiae by integrating the desired biological functions following a standard procedure. Moreover, the modularity of the designed integrative vector enables the modification of the integration target site, in fact the default Homologous Regions can only target the Gal genomic system and users may need to target different DNA sequences.

As reported for the integrative vector for E. coli, the main information about the usage of this integrative vector for yeast is shared in the Registry. We hope to have positively contributed to the diffusion of standard biological parts for yeast, a very interesting chassis for synthetic biology for which only a limited number of parts are available in the Registry and only a few of them has been exaustively characterized.

Self-cleaving affinity tags to easily purify proteins

PHB production

Fusion protein synthesis

Phasins binding activity